Envestnet Portfolio Solutions’s CONMED CNMD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q4
Sell
-3,465
Closed -$249K 1733
2024
Q3
$249K Buy
3,465
+73
+2% +$5.15K ﹤0.01% 1535
2024
Q2
$235K Buy
3,392
+60
+2% +$4.38K ﹤0.01% 1511
2024
Q1
$267K Sell
3,332
-763
-19% -$68K ﹤0.01% 1419
2023
Q4
$448K Buy
4,095
+169
+4% +$17.5K ﹤0.01% 1095
2023
Q3
$396K Buy
+3,926
New +$451K ﹤0.01% 1089

Other funds holding CNMD

Envestnet Portfolio Solutions's CNMD Position: Q4 2024 in Review

Envestnet Portfolio Solutions sold out of CONMED (CNMD) in Q4 2024, closing a stake of 3,465 shares — an estimated $249K sold.

Envestnet Portfolio Solutions first reported a position in CNMD in Q3 2023 and held it in 5 quarters. The position peaked at $448K in Q4 2023. 280 funds tracked by Wall St. Rank hold CNMD as of Q4 2024.

  • Envestnet Portfolio Solutions reported no remaining CONMED position as of Q4 2024 after selling out during the quarter.
  • Envestnet Portfolio Solutions sold 3,465 CONMED shares in Q4 2024, an estimated $249K.
  • Envestnet Portfolio Solutions first reported a position in CONMED in Q3 2023 and held it in 5 quarters.
  • Envestnet Portfolio Solutions's CONMED position peaked at $448K in Q4 2023.
  • 280 funds tracked by Wall St. Rank held CONMED as of Q4 2024.

Based on Envestnet Portfolio Solutions's 13F filing for Q4 2024, filed 10 Feb 2025.